Location of Repository

Financing Pharmaceutical Innovation: How Much Should Poor Countries Contribute? ¤ Center for Global Development Working Paper No. 28

By William Jack Y and Jean O. Lanjouw Z

Abstract

We use a public economics framework to consider how pharmaceuticals should be priced when at least some of the R&D incentive comes from sales revenues. We employ familiar techniques of public …nance to relax some of the restrictions implied in the standard use of Ramsey pricing. In the more general model, poor countries should not necessarily cover even their own marginal costs, and the pricing structure is not related to that which would be chosen by a monopolist in a simple way. We use this framework to examine on-going debates regarding the international patent system as embodied in the WTO’s TRIPS agreement.

Year: 2003
OAI identifier: oai:CiteSeerX.psu:10.1.1.194.8431
Provided by: CiteSeerX
Download PDF:
Sorry, we are unable to provide the full text but you may find it at the following location(s):
  • http://citeseerx.ist.psu.edu/v... (external link)
  • http://are.berkeley.edu/~lanjo... (external link)
  • Suggested articles


    To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.